Increasing Asian American participation in clinical trials by addressing community concerns
- PMID: 24603005
- PMCID: PMC4156927
- DOI: 10.1177/1740774514522561
Increasing Asian American participation in clinical trials by addressing community concerns
Abstract
Background Asian Americans are underrepresented in clinical trials, but little is known about the factors that contribute to clinical trial participation in this population. Purpose The purpose of this study was to identify knowledge, barriers, facilitators, and cultural influences on participating in clinical trials among three Asian American ethnic groups. Concurrently, we sought to identify mechanisms and messages to facilitate dissemination of information and to identify strategies to promote clinical trial participation in this population. Methods Eight focus groups were conducted (n = 103) with Chinese (four groups), Korean (two groups), and Vietnamese (two groups) Americans. Each group was conducted with a moderator and a translator using a standardized guide. Results Participants discuss the benefits of contributing to science, future generations, and their families by being in clinical trials. Some participants think clinical trials would give hope to those with terminal illnesses. A doctor's recommendation, being sick, and needing more options for treatment are motivators for Asian Americans. Having some guarantee of treatment effectiveness and lack of side effects facilitates participation. Cultural or religious beliefs are not believed to prevent clinical trial participation. Limitations This qualitative, two-site study included three Asian American ethnic groups and is not meant to establish prevalence of beliefs. Conclusion Asian Americans need more information about clinical trials and their benefits to science and the larger community. Health-care providers can play pivotal roles in enhancing recruitment of Asian Americans. Basing recruitment goals on percentage representation in most US geographic areas does not provide sufficient numbers to allow for analysis of minorities like Asian American groups. The discovery of important group-specific harms and benefits depends on greater participation of racial/ethnic subgroups.
Conflict of interest statement
None Declared.
Similar articles
-
Involving South Asian patients in clinical trials.Health Technol Assess. 2004 Oct;8(42):iii, 1-109. doi: 10.3310/hta8420. Health Technol Assess. 2004. PMID: 15488164 Review.
-
A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations.Am J Health Promot. 2015 May-Jun;29(5):332-8. doi: 10.4278/ajhp.130514-QUAL-247. Epub 2014 Mar 26. Am J Health Promot. 2015. PMID: 24670073
-
The impact of a community-based clinical trial educational intervention among underrepresented Chinese Americans.Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):424-32. doi: 10.1158/1055-9965.EPI-13-0773. Epub 2013 Oct 3. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24092627 Free PMC article.
-
Navigating the Path to Inclusion: Understanding Barriers and Facilitators to Clinical Trial Participation Among Chinese Older Adults in the United States with Multimorbidity.J Gen Intern Med. 2025 Feb;40(2):393-401. doi: 10.1007/s11606-024-09162-2. Epub 2024 Nov 4. J Gen Intern Med. 2025. PMID: 39495453 Free PMC article.
-
Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.JAMA Netw Open. 2021 May 3;4(5):e218348. doi: 10.1001/jamanetworkopen.2021.8348. JAMA Netw Open. 2021. PMID: 34003274 Free PMC article.
Cited by
-
Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials.Front Oncol. 2024 Feb 29;13:1307459. doi: 10.3389/fonc.2023.1307459. eCollection 2023. Front Oncol. 2024. PMID: 38486933 Free PMC article.
-
Determining call-to-entry rate and recruitment barriers in clinical studies for community clinics serving low-income populations: a cohort study.BMJ Open. 2023 Oct 28;13(10):e077819. doi: 10.1136/bmjopen-2023-077819. BMJ Open. 2023. PMID: 37898484 Free PMC article. Clinical Trial.
-
Identifying Facilitators and Barriers to Increasing COVID-19 Vaccination and Trial Participation in Vaccinated Vietnamese Americans.Health Equity. 2022 Jun 27;6(1):485-493. doi: 10.1089/heq.2022.0032. eCollection 2022. Health Equity. 2022. PMID: 35801146 Free PMC article.
-
Achieving Equity in Asian American Healthcare: Critical Issues and Solutions.J Asian Health. 2021 Jul;1(1):e202103. doi: 10.59448/jah.v1i1.3. Epub 2021 Jul 14. J Asian Health. 2021. PMID: 37872960 Free PMC article.
-
Factors associated with willingness to participate in biospecimen research among Chinese Americans.Biopreserv Biobank. 2014 Apr;12(2):131-8. doi: 10.1089/bio.2013.0081. Biopreserv Biobank. 2014. PMID: 24749880 Free PMC article.
References
-
- Hoeffel EM, Rastogi S, Kim MO, et al. The Asian population: 2010. Washington, DC: US Census Bureau; 2012. [cited 2013 Sep 23]. Available from: http://www.census.gov/prod/cen2010/briefs/c2010br-11.pdf.
-
- Wong C, Hosotani H, Her J. Information on small populations with significant health disparities: A report on data collected on the health of Asian Americans in Massachusetts. [cited 2013 Aug 8];2012 Available from http://www.iaas.umb.edu/publications/general/AA%20Health%20Data.pdf.
-
- American Cancer Society. [cited 2013 Aug 8];American Cancer Society: Cancer Facts & Figures 2012. 2012 Available from http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume....
-
- Kim W, Keefe RH. Barriers to healthcare among Asian Americans. Soc Work in Public Health. 2010;25(3-4):286–295. - PubMed
-
- Homji RM, Lakhoo S, Ray JG. Recruitment of immigrant and ethnic minorities in primary prevention trials of cardiovascular disease. QJM. 2011;104(6):469–476. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical